Get notified when RANI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRani Therapeutics reports Q4 and full-year 2025 financial results
Filed March 26, 2026 · Period ending March 26, 2026 · ~1 min read
Key Changes
-
high
Company issued press release with fourth quarter and full-year 2025 financial results plus corporate update on March 26, 2026. Specific financial figures and operational metrics are in the attached press release.
Item 7.01 view on EDGAR → -
medium
The 8-K filing itself contains no financial details or forward guidance—all substantive information is in Exhibit 99.1, which requires separate review to assess company performance.
Exhibit 99.1 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.
Partner
Trade RANI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify